All treatments
Treatment
PACLITAXEL AHCL 6 mg/ml clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
PRODIGE 55-SOCRATE : A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer
This study is looking at new ways to treat advanced stomach cancer in older patients. It compares two treatments, ramucirumab alone or with paclitaxel, to see which helps people live longer and have a better quality of life.
For: stomach cancer stage IV with metastasesFrance - AuthorisedPhase II and Phase III (Integrated)
A randomized, double-blinded, placebo-controlled, multicenter, phase II/III efficacy and safety study of oral TherO2-01S22 as add-on therapy on top of first line anti-HER2 targeted treatment of patients with Metastatic Breast Cancer TherO2-01S22 in HER2-positive breast cancer: TherO2-MBC Study
This study is testing a new drug, TherO2-01S22, for people with metastatic breast cancer that is HER2-positive. It aims to see how well it works and if it's safe when added to standard treatments. Researchers want to understand if it can shrink tumours.
For: metastatic breast cancerFrance